• Latest Posts

InflaRx receives emergency use authorization for critically ill COVID-19 patients treatment

InflaRx announces plans to apply for Emergency Use Authorization for new COVID-19 drug

More News! 6 Jun 2019

Shares Drop 90% as Antibody for Inflammatory Skin Disease Fails Phase II

Interview 11 Apr 2018

Forget Humira, a New Generation of Inflammation Treatments is on the Horizon

German Biotech Aims for $100M IPO to Support Anti-Inflammatory Drug Development

More News! 13 Oct 2017

German Biotech Gets €47M To Treat Painful Inflammatory Disease


German Biotech raises extra €31M to get first-in-class Antibody through trials

German Biotech launches Phase II in a hot Target for Inflammation